Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer.

Sugyo A, Tsuji AB, Sudo H, Koizumi M, Ukai Y, Kurosawa G, Kurosawa Y, Saga T, Higashi T.

Int J Mol Sci. 2018 Sep 29;19(10). pii: E2979. doi: 10.3390/ijms19102979.

2.

Contributions of yap1 Mutation and Subsequent atrF Upregulation to Voriconazole Resistance in Aspergillus flavus.

Ukai Y, Kuroiwa M, Kurihara N, Naruse H, Homma T, Maki H, Naito A.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01216-18. doi: 10.1128/AAC.01216-18. Print 2018 Nov.

PMID:
30126960
3.

Isolation of human monoclonal antibodies that bind to two different antigens and are encoded by germline VH and VL genes.

Sumitomo-Kondo M, Ukai Y, Iba Y, Ohshima N, Miura K, Takasaki A, Kurosawa Y, Kurosawa G.

Biochem Biophys Res Commun. 2018 Sep 5;503(2):1141-1147. doi: 10.1016/j.bbrc.2018.06.132. Epub 2018 Jul 10.

PMID:
29944883
4.

Combined treatment of pancreatic cancer xenograft with 90Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor.

Aung W, Tsuji AB, Sudo H, Sugyo A, Ukai Y, Kouda K, Kurosawa Y, Furukawa T, Saga T, Higashi T.

World J Gastroenterol. 2017 Nov 14;23(42):7551-7562. doi: 10.3748/wjg.v23.i42.7551.

5.

Radioimmunotherapy of pancreatic cancer xenografts in nude mice using 90Y-labeled anti-α6β4 integrin antibody.

Aung W, Tsuji AB, Sudo H, Sugyo A, Ukai Y, Kouda K, Kurosawa Y, Furukawa T, Saga T.

Oncotarget. 2016 Jun 21;7(25):38835-38844. doi: 10.18632/oncotarget.9631.

6.

Palate and alveolar ridge development in predental infants: a longitudinal study.

Ishida F, Ukai Y, Shimizu T.

Eur J Paediatr Dent. 2016 Jun;17(2):155-63.

PMID:
27377116
7.

Immunotargeting of Integrin α6β4 for Single-Photon Emission Computed Tomography and Near-Infrared Fluorescence Imaging in a Pancreatic Cancer Model.

Aung W, Tsuji AB, Sudo H, Sugyo A, Furukawa T, Ukai Y, Kurosawa Y, Saga T.

Mol Imaging. 2016 Jan 29;15. pii: 1536012115624917. doi: 10.1177/1536012115624917. Print 2016.

8.

Comparison of the diuretic effect of furosemide by different methods of administration in healthy dogs.

Harada K, Ukai Y, Kanakubo K, Yamano S, Lee J, Kurosawa TA, Uechi M.

J Vet Emerg Crit Care (San Antonio). 2015 May-Jun;25(3):364-71. doi: 10.1111/vec.12301. Epub 2015 Apr 17.

PMID:
25885944
9.

Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model.

Sugyo A, Tsuji AB, Sudo H, Nagatsu K, Koizumi M, Ukai Y, Kurosawa G, Zhang MR, Kurosawa Y, Saga T.

Nucl Med Commun. 2015 Mar;36(3):286-94. doi: 10.1097/MNM.0000000000000245.

PMID:
25460304
10.

Annular lupus erythematosus profundus.

Kabuto M, Fujimoto N, Ukai Y, Tanaka T.

Eur J Dermatol. 2014 Sep-Oct;24(5):630-1. doi: 10.1684/ejd.2014.2420. No abstract available.

PMID:
25115404
11.

Evaluation of (89)Zr-labeled human anti-CD147 monoclonal antibody as a positron emission tomography probe in a mouse model of pancreatic cancer.

Sugyo A, Tsuji AB, Sudo H, Nagatsu K, Koizumi M, Ukai Y, Kurosawa G, Zhang MR, Kurosawa Y, Saga T.

PLoS One. 2013;8(4):e61230. doi: 10.1371/journal.pone.0061230. Epub 2013 Apr 5.

12.

Novel human monoclonal antibody against epidermal growth factor receptor as an imaging probe for hepatocellular carcinoma.

Sogawa C, Tsuji AB, Yoshida C, Inubushi M, Furukawa T, Koizumi M, Akahori Y, Ukai Y, Kurosawa G, Kurosawa Y, Saga T.

Nucl Med Commun. 2012 Jul;33(7):719-25. doi: 10.1097/MNM.0b013e3283531d68.

PMID:
22453549
13.

Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.

Nakahata S, Saito Y, Marutsuka K, Hidaka T, Maeda K, Hatakeyama K, Shiraga T, Goto A, Takamatsu N, Asada Y, Utsunomiya A, Okayama A, Kubuki Y, Shimoda K, Ukai Y, Kurosawa G, Morishita K.

Leukemia. 2012 Jun;26(6):1238-46. doi: 10.1038/leu.2011.379. Epub 2012 Jan 6.

PMID:
22289924
14.

Alogliptin as an initial therapy in patients with newly diagnosed, drug naïve type 2 diabetes: a randomized, control trial.

Kutoh E, Ukai Y.

Endocrine. 2012 Jun;41(3):435-41. doi: 10.1007/s12020-012-9596-0. Epub 2012 Jan 17.

PMID:
22249941
15.

Isolation of human mAbs that directly modulate FMS-related tyrosine kinase 3 signaling.

Yamamoto Y, Tsuzuki S, Akahori Y, Ukai Y, Sumitomo M, Murayama Y, Yamamoto K, Inaguma Y, Tokuda M, Abe A, Akatsuka Y, Emi N, Kurosawa Y.

Cancer Sci. 2012 Feb;103(2):350-9. doi: 10.1111/j.1349-7006.2011.02141.x. Epub 2011 Dec 5.

16.

Case of muscle abscess due to disseminated nocardiosis in a patient with autoimmune hemolytic anemia, and review of the published work.

Ukai Y, Fujimoto N, Fujii N, Shirai M, Wakabayashi M, Uenishi T, Koizumi Y, Hodohara K, Shimizu K, Tanaka T.

J Dermatol. 2012 May;39(5):466-9. doi: 10.1111/j.1346-8138.2011.01393.x. Epub 2011 Oct 20. Review.

PMID:
22011194
17.

Glutathione peroxidase 2 in Saccharomyces cerevisiae is distributed in mitochondria and involved in sporulation.

Ukai Y, Kishimoto T, Ohdate T, Izawa S, Inoue Y.

Biochem Biophys Res Commun. 2011 Aug 5;411(3):580-5. doi: 10.1016/j.bbrc.2011.06.189. Epub 2011 Jul 6.

PMID:
21763276
18.

Selection and analysis of anti-cancer antibodies for cancer therapy obtained from antibody phage library.

Kurosawa G, Sumitomo M, Ukai Y, Subere J, Muramatsu C, Eguchi K, Tanaka-Hashiba M, Sugiura M, Ando M, Sato N, Morita M, Inaba K, Morigaki S, Takasaki A, Akahori Y, Miyakawa S, Uyama I, Maeda K, Shiroki R, Hoshinaga K, Mizoguchi Y, Hattori Y, Sugioka A, Sugiura M, Kurosawa Y.

Cancer Sci. 2011 Jan;102(1):175-81. doi: 10.1111/j.1349-7006.2010.01739.x. Epub 2010 Oct 12.

19.

Organotellurium-mediated controlled/living radical polymerization initiated by direct C-Te bond photolysis.

Yamago S, Ukai Y, Matsumoto A, Nakamura Y.

J Am Chem Soc. 2009 Feb 18;131(6):2100-1. doi: 10.1021/ja8099689.

PMID:
19199625
21.

Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic.

Kurosawa G, Akahori Y, Morita M, Sumitomo M, Sato N, Muramatsu C, Eguchi K, Matsuda K, Takasaki A, Tanaka M, Iba Y, Hamada-Tsutsumi S, Ukai Y, Shiraishi M, Suzuki K, Kurosawa M, Fujiyama S, Takahashi N, Kato R, Mizoguchi Y, Shamoto M, Tsuda H, Sugiura M, Hattori Y, Miyakawa S, Shiroki R, Hoshinaga K, Hayashi N, Sugioka A, Kurosawa Y.

Proc Natl Acad Sci U S A. 2008 May 20;105(20):7287-92. doi: 10.1073/pnas.0712202105. Epub 2008 May 12.

22.

RhI-catalyzed aldol-type reaction of organonitriles under mild conditions.

Goto A, Endo K, Ukai Y, Irle S, Saito S.

Chem Commun (Camb). 2008 May 21;(19):2212-4. doi: 10.1039/b800634b. Epub 2008 Mar 26.

PMID:
18463743
23.

Relationships between velocities of pulmonary venous flow and plasma concentrations of atrial natriuretic peptide in healthy dogs.

Hori Y, Ukai Y, Uechi M, Hoshi F, Higuchi S.

Am J Vet Res. 2008 Apr;69(4):465-70. doi: 10.2460/ajvr.69.4.465.

PMID:
18380577
24.

Volume loading-related changes in tissue Doppler images derived from the tricuspid valve annulus in dogs.

Hori Y, Ukai Y, Hoshi F, Higuchi S.

Am J Vet Res. 2008 Jan;69(1):33-8. doi: 10.2460/ajvr.69.1.33.

PMID:
18167084
25.

Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein.

Wakamatsu M, Ishii A, Ukai Y, Sakagami J, Iwata S, Ono M, Matsumoto K, Nakamura A, Tada N, Kobayashi K, Iwatsubo T, Yoshimoto M.

J Neurosci Res. 2007 Jun;85(8):1819-25.

PMID:
17465029
26.

Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice.

Wakamatsu M, Ishii A, Iwata S, Sakagami J, Ukai Y, Ono M, Kanbe D, Muramatsu S, Kobayashi K, Iwatsubo T, Yoshimoto M.

Neurobiol Aging. 2008 Apr;29(4):574-85. Epub 2006 Dec 14.

PMID:
17174013
27.

Ultrafast all optical switching using pulse trapping in birefringent fibers.

Nishizawa N, Ukai Y, Goto T.

Opt Express. 2005 Oct 3;13(20):8128-35.

PMID:
19498842
28.
29.
30.

Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.

Kyoi T, Kitazawa S, Tajima K, Zhang X, Ukai Y.

J Pharmacol Sci. 2004 Jul;95(3):321-8.

31.

Quantitative trait loci for phyllochron and tillering in rice.

Miyamoto N, Goto Y, Matsui M, Ukai Y, Morita M, Nemoto K.

Theor Appl Genet. 2004 Aug;109(4):700-6. Epub 2004 Jun 24.

PMID:
15221143
32.

Inheritance of early elongation ability in floating rice revealed by diallel and QTL analyses.

Nemoto K, Ukai Y, Tang DQ, Kasai Y, Morita M.

Theor Appl Genet. 2004 Jun;109(1):42-7. Epub 2004 Feb 19.

PMID:
14985975
34.

A novel pyrrole derivative, NS-8, suppresses the rat micturition reflex by inhibiting afferent pelvic nerve activity.

Tanaka M, Sasaki Y, Kimura Y, Fukui T, Hamada K, Ukai Y.

BJU Int. 2003 Dec;92(9):1031-6.

35.

[Regulation by autonomic nerves of bladder neck sphincter function--mainly on inhibitory NANC nerves].

Ukai Y, Noda K, Toda N.

Nihon Yakurigaku Zasshi. 2003 May;121(5):299-306. Japanese.

PMID:
12784731
36.
37.
38.

Functional role of inhibitory and excitatory nerves in the porcine lower urinary tract.

Noda K, Takebe M, Oka M, Hirouchi M, Ukai Y, Toda N.

Eur J Pharmacol. 2002 Dec 5;456(1-3):81-90.

PMID:
12450573
39.

[Current state on development of neuroprotective agents for cerebral ischemia].

Hirouchi M, Ukai Y.

Nihon Yakurigaku Zasshi. 2002 Aug;120(2):107-13. Review. Japanese.

PMID:
12187623
40.

A new enzymic method for the isolation and culture of human bladder body smooth muscle cells.

Ma F-, Higashira H, Ukai Y, Hanai T, Kiwamoto H, Park YC, Kurita T.

Neurourol Urodyn. 2002;21(1):71-9.

PMID:
11835427
41.

Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression.

Morino K, Katsumi H, Akahori Y, Iba Y, Shinohara M, Ukai Y, Kohara Y, Kurosawa Y.

J Immunol Methods. 2001 Nov 1;257(1-2):175-84.

PMID:
11687251
43.

Detection of closely linked multiple quantitative trait loci using a genetic algorithm.

Nakamichi R, Ukai Y, Kishino H.

Genetics. 2001 May;158(1):463-75.

44.

Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance.

Noda K, Oka M, Ma FH, Kitazawa S, Ukai Y, Toda N.

Eur J Pharmacol. 2001 Mar;415(2-3):209-16.

PMID:
11275001
47.

Effective plasma concentration of a novel Na+/Ca2+ channel blocker NS-7 for its cerebroprotective actions in rats with a transient middle cerebral artery occlusion.

Aoki Y, Tamura M, Itoh Y, Seto T, Nonaka K, Mukai H, Ukai Y.

J Pharmacol Exp Ther. 2001 Feb;296(2):306-11.

PMID:
11160611
48.

Determination and bioimaging method for nitric oxide in biological specimens by diaminofluorescein fluorometry.

Itoh Y, Ma FH, Hoshi H, Oka M, Noda K, Ukai Y, Kojima H, Nagano T, Toda N.

Anal Biochem. 2000 Dec 15;287(2):203-9.

PMID:
11112265

Supplemental Content

Support Center